Cytophage Technologies Ltd.
CYTO.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.75M | 2.68M | 4.12M | -- | |
| Total Receivables | 298.60K | 279.40K | 292.80K | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 6.30K | 4.80K | 10.60K | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 63.50K | 87.30K | 188.70K | -- | |
| Total Current Assets | 2.12M | 3.05M | 4.61M | -- | |
|
|
|||||
| Total Current Assets | 2.12M | 3.05M | 4.61M | -- | |
| Net Property, Plant & Equipment | 2.43M | 2.29M | 1.84M | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | 4.54M | 5.34M | 6.46M | -- | |
|
|
|||||
| Total Accounts Payable | 154.00K | 175.30K | 197.90K | -- | |
| Total Accrued Expenses | 124.40K | 125.30K | 191.20K | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 220.90K | 218.10K | 239.60K | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 499.30K | 518.70K | 628.70K | -- | |
|
|
|||||
| Total Current Liabilities | 499.30K | 518.70K | 628.70K | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 955.00K | 979.00K | 1.03M | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 1.45M | 1.50M | 1.65M | -- | |
|
|
|||||
| Common Stock & APIC | 18.71M | 18.40M | 18.58M | -- | |
| Retained Earnings | -19.03M | -17.99M | -17.26M | -- | |
| Treasury Stock & Other | 3.41M | 3.44M | 3.48M | -- | |
| Total Common Equity | 3.09M | 3.85M | 4.80M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 3.09M | 3.85M | 4.80M | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 3.09M | 3.85M | 4.80M | -- | |
|
|
|||||